ddt has been researched along with Glycogen Storage Disease Type I in 1 studies
1,1-bis(p-chlorophenyl)-2,2,2-trichloroethane: structure in first source
Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandifer, SH | 1 |
1 other study available for ddt and Glycogen Storage Disease Type I
| Article | Year |
|---|---|
The susceptibility of the fetus and chils to chemical pollutants. Industrial and agricultural chemicals.
Topics: Adult; Agriculture; Atropine; Birth Weight; Black or African American; Blood; Body Burden; DDT; Envi | 1974 |